Abstract
Human intestinal organoids (HIOs) have been reported to exert their functions in a way that mimics living organs, and HIOs-derived monolayers are expected to be applied to in vitro intestinal pharmacokinetic studies. However, HIOs are established from human tissue, which raises issues of availability and ethics. In the present study, to solve these problems, we have established intestinal organoids using commercially available cryopreserved human intestinal epithelial cells (C–IOs), and compared their functions with biopsy-derived human intestinal organoids (B–IOs) from a pharmacokinetic point of view. Both C–IOs and B–IOs reproduced the morphological features of the intestinal tract and were shown to be composed of epithelial cells. Monolayers generated from C–IOs and B–IOs (C-IO-2D, B-IO-2D, respectively) structurally mimic the small intestine. The C–IOs showed gene expression levels comparable to those of the B–IOs, which were close to those of adult human small intestine. Importantly, the C–IOs-2D showed levels of pharmacokinetics-related protein expression and activity—including cytochrome P450 3A4 (CYP3A4) and carboxylesterase 2 (CES2) enzymatic activities and P-glycoprotein (P-gp) transporter activities —similar to those of B–IOs-2D. This study addresses the difficulties associated with B–IOs and provides fundamental characteristics for the application of C–IOs in pharmacokinetic studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.